Effect of liver fibrosis with modified splenopneumopexy

doi:10.3877/cma.j.issn.1647-0793.2013.02.009

Abstract

Abstract:

Objective

To evaluate the changes of the serum markers for hepatic fibrogenesis in patients of portal hypertension after modified splenopneumopexy treatment.

Methods

From June 2008 to December 2012, 32 patients with portal hypertension were given modified splenopneumopexy in the First Affiliated Hospital of Zhengzhou University. The levels of COL-Ⅲ, COL-Ⅳ, MMP-1, and TIMP-1were recorded separately before and 6 months after the operation for a statistical comparison.

Results

After 6 months, the levels of COL-Ⅲ decreased from (20.25±3.20) μg/L to (16.32±2.35) μg/L, COL-Ⅳ decreased from (112.21±23.90) μg/L to (57.32±18.74) μg/L, the levels of MMP-1 increased from (16.68±8.56) μg/L to (26.85±8.95) μg/L, TIMP-1 decreased from (227.56±76.84) μg/L to (132.35±62.42) μg/L. There were significantly statistical differences between any two groups, P<0.01.

Conclusion

The modified splenopneumopexy helps to slow down the degree of liver fibrosis.

Key words: Portal hypertension, Modified splenopneumopexy, Liver fibrosis

Xiao-wei DANG, Zhi-qiang YANG, Shi-shi QIAO, Da-qian XU, Peng LI, Zhao-yang WANG, Zhen-tao YAO, Pei-qin XU. Effect of liver fibrosis with modified splenopneumopexy[J]. Chinese Archives of General Surgery(Electronic Edition), 2013, 07(02): 118-120.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhptwkxwx.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1647-0793.2013.02.009

https://zhptwkxwx.cma-cmc.com.cn/EN/Y2013/V07/I02/118

Figures/Tables 1

References 9

1	党晓卫，马秀现，许培钦. 改良脾-肺固定术治疗布-加综合征:附126例报告. 中国普通外科杂志, 2006, 15(12): 884-886.
2	杨镇，冷希圣. 门静脉高压症外科治疗策略和手术适应症. 继续医学教育, 2006, 20(9): 22-25.
3	曾虎，聂晚频，刘海宁. 脾切除对肝纤维化大鼠肝脏PDGF-B表达及血清PDGF-BB水平的影响. 中华肝胆外科杂志, 2011, 17(4): 305-308.
4	Foschi FG, Trevisani F, Loggi E, et al. Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophil granulocytes in patients with liver cirrhosisJ. Int Arch Allergy Immunol, 2005, 137(3): 258-262.
5	屈朝霞，钱忠义，王文林. COL-Ⅰ、COL-Ⅲ和TIMP-1在实验性肝纤维化中作用的研究进展. 中国病原生物学杂志, 2009, 22 (4): 311-313.
6	曾民德, 王泰龄, 王宝恩. 肝纤维化诊断及疗效评估共识. 2008年贵州省医学会消化及内镜学分会学术大会论文汇编, 2008.
7	孟庆生，张桂珍，裘银久, 等. 慢性乙型肝炎血清MMP-1的变化及临床意义. 中国误诊学杂志, 2009, 9(30): 7344-7345.
8	李明意，姚金科，杨永光, 等. MMP9、TIMP1基因在原发性肝癌中的表达[J/CD]. 中华普通外科学文献:电子版, 2007, 1(1): 33.
9	杨志强，党晓卫，乔师师, 等. 改良脾-肺固定术治疗门静脉高压症疗效再评价.中华实验外科杂志, 2012, 29(4): 1.

?	例数	COL-Ⅲ	COL-Ⅳ	MMP-1	TIMP-1
术前	32	20.25±3.20	112.21±23.90	16.68±8.56	227.56±76.84
术后6月	28	16.32±2.35	57.32±18.74	26.85±8.95	132.35±62.42
t值	?	5.355	9.797	4.495	5.219
P值	?	< 0.01	< 0.01	< 0.01	< 0.01

?	例数	COL-Ⅲ	COL-Ⅳ	MMP-1	TIMP-1
术前	32	20.25±3.20	112.21±23.90	16.68±8.56	227.56±76.84
术后6月	28	16.32±2.35	57.32±18.74	26.85±8.95	132.35±62.42
t值	?	5.355	9.797	4.495	5.219
P值	?	< 0.01	< 0.01	< 0.01	< 0.01

[1]	Yunkai Luo, Caoxin Yan, Xuanxuan Zhang, Rumei Li, Wenqian Wang, Hanghang Hong, Bin Xia, Weipu Zou, Shanshan Zhang, Jian Chen. Value of sound touch elastography in detecting spleen stiffness for assessment of liver fibrosis in patients with chronic hepatitis B [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2022, 19(11): 1232-1237.
[2]	Qinyuan Li, Changfeng Dong, Cheng Feng, Zhiyan Li, Li Liu, Binghao He, Wei Jiang, Wenshuo Tian, Shuai Yang. Multimodal method based on elastography to stage liver fibrosis in chronic hepatitis B patients [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2022, 19(09): 976-982.
[3]	Na Shi, Wenqian Qiu, Danqing He, Chaoxue Zhang, Ping Mao, Yanting Yang. Value of transient elastography in assessing efficacy of antiviral therapy in chronic hepatitis B patients [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2022, 19(05): 428-433.
[4]	Min Li, Shiying Yang, Xiaoqin Gao, Dan Zhou, Xiao Tang, Liting Zhang. Advances on the association of vitamin A and chronic liver diseases [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2024, 18(02): 65-70.
[5]	Qi Zhang, Zhen Ma. Progress on influencing factors and biomarkers for hepatic fibrosis progression of hepatitis C [J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2024, 18(01): 1-6.
[6]	Meini Ye, Sijia Liu, Yuwei Zang, Yunjian Liu. Research progress on portal vein thrombosis in liver cirrhosis [J]. Chinese Archives of General Surgery(Electronic Edition), 2024, 18(05): 379-384.
[7]	Lina Wu, Lin Wei, Zhigui Zeng, Liang Zhang, Enhui He, Yule Tan, Zhijun Zhu, Liying Sun. Pulmonary arterial hypertension targeted drugs combined with liver transplantation for severe portalpulmonary hypertension: a case report [J]. Chinese Journal of Transplantation(Electronic Edition), 2022, 16(06): 376-378.
[8]	Fei Wang, Zheng Chen, Decai Yu, Yajuan Cao. Minimally invasive surgical treatment of primary liver cancer with portal hypertension [J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2024, 17(05): 306-310.
[9]	Yidan Cai, Fang Jian, Zhiqiang Zhang, Li Chen, Shian Zhang, Lei Xia, Mei Ruan, Dongliang Li. Impact of transjugular intrahepatic portosystemic shunt on gut microbiota and liver function in patients with cirrhotic portal hypertension [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2024, 14(05): 285-293.
[10]	Yanping Liang, Yanrou Chen, Yunxiao Liang, Feihu Bai, Bin Wu, Xing Wang. Investigation report on endoscopic management of esophagogastric variceal bleeding in portal hypertension in Southern China [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(05): 390-395.
[11]	Zexue Qi, Lianhui Zhao, Guangchuan Wang, Chunqing Zhang. Discuss of the progress of clinical application of transjugular intrahepatic portal shunt from domestic expert consensus recommendation [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(03): 193-196.
[12]	Fengshang Zhu, Ling She, Yongnian Ding, Changqing Yang. Application of the five-step questioning method in clinical teaching of cirrhotic portal hypertension [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(02): 116-118.
[13]	Minimally Invasive Intervention Collaboration Group of the Gastroenterology Branch of the Chinese Medical Association. Consensus on hemodynamic classification and clinical management of gastric varices [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2022, 12(06): 325-333.
[14]	Hao Li, Qishuai Chen, Fazhu Fei, Ningwei Zhang, Yuandong Li, Shuochen Wang, Bin Ren. Progress in noninvasive diagnosis of liver fibrosis in chronic liver disease [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(09): 863-867.
[15]	Endoscopic Diagnosis and Treatment of Esophagogastric Varices Group, Chinese Society of Digestive Endoscopology, Beijing 100710, China. Chinese expert consensus on endoscopic cyanoacrylate injection for gastrointestinal varices in patients with portal hypertention induced by liver cirrhosis [J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2022, 09(04): 193-206.

Please choose a citation manager

Content to export